Skip to main content
. 2023 Jan 20;129:63–69. doi: 10.1016/j.ijid.2023.01.021

Figure 4.

Figure 4

Multivariable analysis of factors associated with primary and secondary outcomes among persons receiving generic remdesivir (n = 530).

CI, confidence interval; CRP, C-reactive protein; NLR, neutrophil-to-lymphocyte ratio; OR, odds ratio; SpO2, oxygen saturation on room air; VOC, variants of concern.